Drug discovery and development
Keywords |
Classification |
Keyword |
CNAEF |
Health |
Instance: 2019/2020 - 1S (of 09-09-2019 to 31-07-2020)
Cycles of Study/Courses
Acronym |
No. of Students |
Study Plan |
Curricular Years |
Credits UCN |
Credits ECTS |
Contact hours |
Total Time |
PDFTEC |
13 |
Current Studies Plan |
1 |
- |
3 |
14 |
81 |
Teaching language
Portuguese and english
Objectives
Provide students the opportunity to understand, evaluate, and engage with the entire process of drug discovery and development. This unit prepares graduates for a sustainable career with a biotechnology firm, pharmaceutical company, contract research organization, or academic research laboratory.
Learning outcomes and competences
Provide students the opportunity to understand, evaluate, and engage with the entire process of drug discovery and development. This unit prepares graduates for a sustainable career with a biotechnology firm, pharmaceutical company, contract research organization, or academic research laboratory.
At the end of the course, the student is expected to understand how medicines and poisons act, and how they reach their biological targets. The student is expected to understand the major rules of quantitative pharmacodynamics and pharmacokinetics relevant to medical treatment and poisoning. This is achieved by the standard syllabus of general pharmacology and of special pharmacology of drugs with multiple systemic actions.
Working method
Presencial
Program
Blended learning is used (face-to-face complemented with online support). The module carries 3 ECTS. By convention adopted at the University of Porto, 1 ECTS=27 hours of student workload. The total workload of the student is estimated to be 81 hours. Face-to-face teaching and learning activities take 27 hours and run for 9 weeks: one lecture per week (1 hour each), one small-group tutorial per week (2 hours each). Every student is given a password to use a complete e-learning platform on a 24-hour basis. The final exam is a 60 minutes test with 50 extended-matching and multiple-choice questions.
Mandatory literature
Ed: R.G. Hill, H.P. Rang; Drug Discovery and Development: Technology In Transition, 2nd Edition, Elsevier – Churchill Livingstone, 2013
B.H. Littman, R. Krishna,; Translational Medicine and Drug Discovery, , Cambridge University Press, 2011
L.L. Burton, B. Chabner, B. Knollman; Goodman & Gilman´s The Pharmacological Basis of Therapeutics, McGraw Hill, 2011
B.G. Katzung, S.B. Masters, A.J. Trevor; Basic & Clinical Pharmacology, Ed, McGraw Hill, 2009
Teaching methods and learning activities
Blended learning is used (face-to-face complemented with online support). The module carries 3 ECTS. By convention adopted at the University of Porto, 1 ECTS=27 hours of student workload. The total workload of the student is estimated to be 81 hours. Face-to-face teaching and learning activities take 27 hours and run for 9 weeks: one lecture per week (1 hour each), one small-group tutorial per week (2 hours each). Every student is given a password to use a complete e-learning platform on a 24-hour basis. The final exam is a 60 minutes test with 50 extended-matching and multiple-choice questions.
Evaluation Type
Evaluation with final exam
Assessment Components
Designation |
Weight (%) |
Exame |
100,00 |
Total: |
100,00 |
Amount of time allocated to each course unit
Designation |
Time (hours) |
Apresentação/discussão de um trabalho científico |
2,00 |
Elaboração de projeto |
23,00 |
Estudo autónomo |
30,00 |
Frequência das aulas |
14,00 |
Trabalho escrito |
12,00 |
Total: |
81,00 |
Eligibility for exams
Lectures.
Practical classes / laboratory.
Tutorials
Calculation formula of final grade
The evaluation is distributed from 0-20 values
The final exam is a 60 minutes test with 50 extended-matching and multiple-choice questions.